Top Markets
Coin of the day
Recro Pharma, Inc. Recro Pharma, Inc.

Recro Pharma, Inc.

REPH
Rangering i aksjer #25697
Recro Pharma, Inc. operates as a contract development and manufacturing... Recro Pharma, Inc. operates as a contract development and manufacturing organization (CDMO), offering comprehensive services for the development, production, and packaging of diverse therapeutic dosage forms. The company primarily specializes in small molecule therapeutic development, serving both domestic U.S. and international clients. Its extensive capabilities encompass a wide array of formats, including oral solid doses, sterile injectable solutions, oral liquid preparations, tablets, topical formulations, liquid/powder-filled capsules, ophthalmic droppers, liposomal products, and nano/microparticles. Furthermore, Recro Pharma provides specialized services such as aseptic fill/finish, lyophilization (freeze-drying), final packaging, and logistics management. Originally founded as Recro Pharma I, Inc., the company underwent a name change to Recro Pharma, Inc. in August 2008. The organization was established in 2007 and is headquartered in Exton, Pennsylvania.
Aksjekurs
$2.09
Sist synkronisert: 2022-03-21
Markedsverdi
$47.04M
Endring (1 dag)
-0.48%
Endring (1 år)
0.00%
Land
US
Handel Recro Pharma, Inc. (REPH)

Kategori

Historikk for aksjesplitt for Recro Pharma, Inc. (REPH)
Aksjen Recro Pharma, Inc. (symbol: REPH) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 21, 2026.
Én REPH-aksje kjøpt før Aug 21, 2026 tilsvarer i dag 0 REPH-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter